Doxazosin Mesylate

Form: Extended-release (ER) capsules

Strength: 4 mg, 8 mg, and 12 mg

Reference Brands: Cardura XL

Category: Drugs Using Osmotic Pump Systems

Cardura XL® (doxazosin mesylate) is regulated in the EU and US, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in accordance with GMP standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity under MDR standards. These formulations undergo validation, stability testing, and audits, with detailed documentation including safety profiles, clinical trial data, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to high-quality doxazosin formulations supporting hypertension and BPH management worldwide, promoting treatment safety and effectiveness.